AHAS1: A pilot trial to determine whether reduced dose intravenous Abciximab achieves optimal platelet inhibition in acute ischemic stroke "AHAS1"

Recruiting

Phase N/A Results N/A

References

Source for Trial Information

  • Presented at 2010 International Stroke Conference (February 2010).